Abstract
We herein describe a 40-year-old woman with hyperprolactinemia, an empty sella and two extrasellar intracranial recurrent tumors which were revealed 23 years after the first transfrontal craniotomy and 18 years after the second transfrontal surgery and irradiation to a provable prolactin-producing pituitary macroadenoma. One recurrent tumor was in the right orbital apex causing right oculomotor nerve palsy, and the other tumor was in the right apex partispetrosae and foramen jugulare. Although her serum prolactin level decreased after the administration of bromocriptine mesilate, and the size of the two tumors remained unchanged, a malignant fibrous histiocytoma, which might have been induced by the irradiation 18 years before, grew rapidly in the right suprasellar-prepontine cistern to the right pedunculus cerebralis, leading to a poor prognosis. This case confirmed the importance of the life-lasting follow-up of pituitary adenomas treated with surgery and/or irradiation therapy. Not only ectopic recurrence of the primary tumor but also post-irradiation tumors may become apparent long after the removal of the primary tumor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lundberg P.O., Drettner B., Hemmingsson A., Stenkvist B., Wide L. The invasive pituitary adenoma. A prolactin-producing tumor. Arch. Neurol. 1977, 34: 742–749.
Virapongse C., Bhimani S., Saewar M., Greenberg A., Kim J. Prolactin-secreting pituitary adenomas: CT appearance in diffuse invasion. Radiology 1984, 152: 447–451.
Gyori E., Gregg P.A., Breach M. Invasive pituitary adenoma coexisting with infiltrating temporal lobe glioma. South. Med. J. 1992, 85: 1134–1137.
Gasser R.W., Finkenstedt G., Skrabal F., Twerdy K., Grunert V., Mayr U., Frommhold H., Zur Nedden D., Feichtinger J., Hofstaedter F. Multiple intracranial metastases from a prolactin secreting pituitary tumor. Clin. Endocrinol. 1985, 22: 17–27.
Scheithauer B.W., Randall R.V., Laws E.R. Jr., Kovacs K.T., Horvath E., Whitaker M.D. Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases. Cancer 1985, 55: 598–604.
Popovic E.A., Vattuone J.R., Siu K.H., Busmanis I., Pullar M.J., Dowling J. Malignant prolactinomas. Neurosurgery 1991, 29: 127–130.
Atienza D.M., Vigersky R.J., Lack E.E., Carriaga M., Rusnock E.J., Tsou E., Cerrone F., Kattah J.G., Sausville E. Prolactin-producing pituitary carcinoma with pulmonary metastases. Cancer 1991, 68: 1605–1610.
Walker J.D., Grossman A., Anderson J.V., Ur E., Trainer P.J., Benn J., Lowy C., Sönksen P.H., Plowman P.N., Lowe D.G., Doniach I., Wass L.A.H., Besser G.M. Malignant prolactinoma with extracranial metastases: a report of three cases. Clin. Endocrinol. 1993, 38: 411–419.
Assies J., Verhoeff N.P.L.G., Bosch D.A., Hofland L.J. Intracranial dissemination of a macroprolactinoma. Clin. Endocrinol. 1993, 38: 539–546.
Jones A. Radiation oncogenesis in relation to the treatment of pituitary tumors. Clin. Endocrinol. 1991, 35: 379–397.
Gonzalez-Vitale J.C., Slavin R.E., McQueen J.D. Radiation-induced intracranial malignant fibrous histiocytoma. Cancer 1976, 37: 2960–2963.
Jefferson G. The invasive adenomas of the anterior pituitary. In: The Sherrington Lectures; vol 3. University of Liverpool Press, Liverpool, 1954, pp. 1–63.
Karga H.J., Alexander J.M., Hedley-Whyte E.T., Klibanski A., Jameson L.J. Ras mutations in human pituitary tumors. J. Clin. Endocrinol. Metab. 1992, 74: 914–919.
Pei L., Melmed S., Scheithauer B., Kovacs K., Prager D. H-ras mutations in human pituitary carcinoma metastases. J. Clin. Endocrinol. Metab. 1994, 78: 842–846.
Gonsky R., Herman V., Melmed S., Fagin J. Transforming DNA sequences present in human prolactin-secreting pituitary tumors. Mol. Endocrinol. 1991, 5: 1687–1695.
Shimon I., Hinton D.R., Weiss M.H., Meled S. Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness. Clin. Endocrinol. 1998, 48: 23–29.
Larsson C., Skogseid B., Oberg K., Nakamura Y., Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988, 332: 85–87.
Courseaux A., Grosgeorge J., Gaudray P., Pannett A.A., Forbes S.A., Williamson C., Bassett D., Thakker R.V., Teh B.T., Farnebo F., Shepherd J., Skogseid B., Larsson C., Giraud S., Zhang C.X., Salandre J., Calender A. Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on MEN1. Genomics 1996, 37: 354–365.
Ponder B.A., Smith D. The MEN II syndromes and the role of the ret proto- oncogene. Adv. Cancer Res. 1996, 70: 179–222.
Scheithauer B.W., Laws E.R. Jr., Kovacs K., Horvath E., Randall R.V., Carney J.A. Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Semin. Diagn. Pathol. 1987, 4: 205–211.
Cahan W.G., Woodward H.Q., Higinbotham N.L., Stewart F.W., Coley L. Sarcoma arising in irradiated bone. Cancer 1948, 28: 1087–1099.
Robinson E., Neugut A.I., Wylie P. Clinical aspects of postirradiation sarcomas. J. Natl. Cancer Inst. 1988, 80: 233–240.
Amendola B.E., Amendola M.A., McClatchey K.D. Radiation-induced malignant fibrous histiocytoma: a report of five cases including two occurring post whole brain irradiation. Cancer Invest. 1985, 3: 507–513.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fujikawa, M., Okamura, K., Sato, K. et al. Multiple intracranial recurrent tumors with hyperprolactinemia combined with a parasellar malignant fibrous histiocytoma long after transfrontal surgery and irradiation to a pituitary adenoma. J Endocrinol Invest 24, 448–453 (2001). https://doi.org/10.1007/BF03351046
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03351046